Get started
Author

Robert Godemann

Observed names: R. Godemann, Robert Godemann Aventis
Institution: Evotec (Germany)
OpenAlex ID: A5017579545
Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease
1998 · A. Ebneth, R. Godemann, et al. · The Journal of Cell Biology · 829
Sequential phosphorylation of Tau by glycogen synthase kinase‐3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer‐specific epitope of antibody AT100 and requires a paired‐helical‐filament‐like conformation
1998 · Qingyi Zheng‐Fischhöfer, Jacek Biernat, et al. · European Journal of Biochemistry · 336
PDF
The Endogenous and Cell Cycle-dependent Phosphorylation of tau Protein in Living Cells: Implications for Alzheimer’s Disease
1998 · Susanne Illenberger, Qingyi Zheng-Fischhöfer, et al. · Molecular Biology of the Cell · 305
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
2018 · Hans D. Brightbill, Eric Suto, et al. · Nature Communications · 132
PDF
Phosphorylation of tau protein by recombinant GSK‐3β: pronounced phosphorylation at select Ser/Thr‐Pro motifs but no phosphorylation at Ser262 in the repeat domain
1999 · R. Godemann, J. Biernat, et al. · FEBS Letters · 110
PDF
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)
2016 · Georgette M. Castanedo, Nicole Blaquiere, et al. · Journal of Medicinal Chemistry · 65
Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease
2009 · Antje Willuweit, Joachim Velden, et al. · PLoS ONE · 60
PDF
The multiple roles of computational chemistry in fragment-based drug design
2009 · Richard Law, Oliver Barker, et al. · Journal of Computer-Aided Molecular Design · 60
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase
2018 · Nicole Blaquiere, Georgette M. Castanedo, et al. · Journal of Medicinal Chemistry · 57
Fragment-Based Discovery of BACE1 Inhibitors Using Functional Assays
2009 · Robert Godemann, James Madden, et al. · Biochemistry · 52
PDF
Fragment-based discovery and optimization of BACE1 inhibitors
2010 · James Madden, Jenny R. Dod, et al. · Bioorganic & Medicinal Chemistry Letters · 42
Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1)
2019 · Jianwen A. Feng, Patrick Lee, et al. · ACS Medicinal Chemistry Letters · 10
Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug design
2023 · James J. Crawford, Jianwen Feng, et al. · Bioorganic & Medicinal Chemistry Letters · 7
Tau Protein: Role in Intracellular Traffic and Development of Cell Polarity
2000 · E.-M. Mandelkow, J. Biernat, et al. · Research and perspectives in Alzheimer's disease · 2
Selective inhibition of NF-kB inducing kinase (NIK) is therapeutically efficacious in IFNα-accelerated lupus nephritis prone mice
2017 · Hans D Brightbill, Eric Suto, et al. · The Journal of Immunology · 1
Structure of Bace (beta secretase) in complex with ligand EV2
2009 · R. Godemann, J. Madden, et al. · Worldwide Protein Data Bank
Structure of bace (beta secretase) in Complex with EV0
2009 · R. Godemann, J. Madden, et al. · Worldwide Protein Data Bank
Tau protein and Alzheimer's disease: Phosphorylation and role in intracellular trafficking
2000 · Eva-Maria Mandelkow, Andreas Ebneth, et al. · Neurobiology of Aging
513 Phosphorylation of tau by GSK3 and effects on microtubule dynamics
1996 · R. Godemann, G. Schmitt-Ulms, et al. · Neurobiology of Aging
Works count: 21
Citation count: 2,068
H-index: 11
I10-index: 12
Year
Topic
Type